Synthetic Biologics, Inc News Headlines

SYN 
$1.72
*  
0.01
0.58%
Get SYN Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading SYN now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    SYN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Teva Pharmaceutical Industries: Is It Time To Buy Or Sell?
1/1/2015 3:27:00 AM - Seeking Alpha


Synthetic Biologics Commences Phase Ib Study on SYN-004 - Analyst Blog
12/31/2014 2:40:00 PM - Investopedia


Synthetic Biologics Commences Phase Ib Study on SYN-004 - Analyst Blog
12/31/2014 2:40:00 PM - Zacks.com


ARIA Widens Sales Turf, NRX Skips A Beat, NDRM Triples On Parkinson''s Study
12/30/2014 11:22:00 PM - RTT News


ARIA Widens Sales Turf, NRX Skips A Beat, NRDM Triples On Parkinson's Study
12/30/2014 11:12:00 PM - RTT News


Synthetic Biologics Unveils Top-Line Safety Data on SYN-004 - Analyst Blog
12/29/2014 5:40:00 PM - Zacks.com


Synthetic Biologics Unveils Top-Line Safety Data on SYN-004 - Analyst Blog
12/29/2014 5:40:00 AM - Investopedia


Synthetic Biologics Initiates Phase 1a Clinical Trial Of SYN-004 - Quick Facts
12/2/2014 8:28:00 AM - RTT News


Health Care Sector Update for 11/24/2014: SYN,RNA,BMRN,TTHI,TTH.TO
11/24/2014 1:41:10 PM - MT Newswires


Health Care Sector Update for 11/14/2014: PDLI, CASI, SYN
11/14/2014 7:59:05 AM - MT Newswires


Sector Update: Health-Care Shares Higher Pre-Bell
10/22/2014 7:40:32 AM - MT Newswires


Sector Update: Health Care
10/22/2014 7:36:33 AM - MT Newswires


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog
9/16/2014 4:00:00 PM - Zacks.com


Monday Sector Laggards: Biotechnology, Application Software Stocks
9/15/2014 12:33:48 PM - BNK Invest


Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
7/10/2014 11:33:00 AM - Seeking Alpha


Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting MS Data
5/19/2014 5:53:00 PM - Seeking Alpha


Healthcare Stocks Ending in the Red; Synthetic Biologics Rises After Outlining Trial Schedule for c. Diff Drug
5/15/2014 2:52:52 PM - MT Newswires


Sector Update: Healthcare
5/15/2014 2:52:13 PM - MT Newswires


AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha


Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha


OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha


Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5% - Tale of the Tape
3/20/2014 8:04:01 AM - Zacks.com


Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk
3/11/2014 8:30:00 AM - Seeking Alpha


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha